Amtech Systems to Participate in the 37th Annual Roth Conference
Get Alerts ASYS Hot Sheet
Join SI Premium – FREE
TEMPE, Ariz.--(BUSINESS WIRE)-- Amtech Systems, Inc. ("Amtech") (NASDAQ: ASYS), a manufacturer of equipment and consumables for semiconductor fabrication and packaging, announces that Robert Daigle, Chief Executive Officer, and Wade Jenke, Chief Financial Officer, will participate in the 37th Annual Roth Conference in Dana Point, California, on Monday, March 17, 2025.
Management will be available for one-on-one and small group meetings with institutional investors on Monday, March 17, 2025. For more information about the conference or to request a meeting, please contact your Roth sales representative.
About Amtech Systems, Inc.
Amtech Systems, Inc. is a leading, global manufacturer of equipment and consumables for semiconductor fabrication and packaging. We sell process equipment and services used in the fabrication of semiconductor devices, such as silicon carbide (SiC), silicon power, electronic assemblies and modules to semiconductor device and module manufacturers worldwide, particularly in Asia, North America and Europe. Our strategic focus is on growth opportunities which leverage our strengths in thermal and substrate processing. Amtech's products are recognized under the leading brand names BTU International, Entrepix, Inc., PR Hoffman™ and Intersurface Dynamics, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250204963249/en/
Amtech Systems, Inc.
Wade Jenke
Chief Financial Officer
[email protected]
Sapphire Investor Relations, LLC
Erica Mannion or Michael Funari
617-542-6180
[email protected]
Source: Amtech Systems, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UAE Opens 15th UN Congress on Crime Prevention and Criminal Justice and Launches Pledge4Justice with First Pledge of Up to USD 5 Million
- Dogecoin News Today: A September 24 Transfer Sends 250M DOGE to Binance as Remittix Confirms Its Token Debut
- 2026 IMS | IASO Bio Presented First-in-Human Data of BCMA-Targeted In Vivo CAR-T Cell Therapy IASO206
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
American Technology ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share